Sonoma Pharmaceuticals, Inc. (SNOA) Investor Relations Documents

Sonoma Pharmaceuticals, Inc. (SNOA) investor relations documents from the company's IR site: 1 presentation, 33 press releases; latest deck 2026-01-09. Read in-app with summaries. First-party data.

https://d1io3yog0oux5.cloudfront.net/_3cdd6451e8ddd68aed326af04b0df36c/sonomapharma/db/359/2920/pdf/IR+Presentation+January+2026.pdf — Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid (HOCl) products for global healthcare, currently operating at 40% manufacturing capacity.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releaseSonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adju
2026-06-30Press releaseSonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound
2026-04-24Press releaseSonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
2026-03-24Press releaseSonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
2026-03-18Press releaseSonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand fo
2026-02-10Press releaseSonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
2026-02-10Press releasePDF
2026-01-28Press releaseSonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Qualit
2026-01-09Presentationhttps://d1io3yog0oux5.cloudfront.net/_3cdd6451e8ddd68aed326af04b0df36c/sonomapharma/db/359/2920/pdf/IR+Presentation+January+2026.pdf
2025-11-04Press releasePDF
2025-08-07Press releasePDF
2025-06-17Press releasePDF
2025-02-05Press releasePDF
2024-11-07Press releasePDF
2024-08-08Press releasePDF
2024-06-17Press releasePDF
2024-02-08Press releasePDF
2023-11-13Press releasePDF
2023-08-10Press releasePDF
2023-06-22Press releasePDF
2023-02-14Press releasePDF
2022-11-14Press releasePDF
2022-08-11Press releasePDF
2022-07-13Press releasePDF
2022-02-11Press releasePDF
2021-11-15Press releasePDF
2021-08-16Press releasePDF
2021-07-14Press releasePDF
2021-02-16Press releasePDF
2020-11-20Press releasePDF
2020-08-14Press releasePDF
2020-07-10Press releasePDF
2020-02-14Press releasePDF
Press releaseSonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

SNOA overview · SNOA earnings · SNOA financials · SNOA KPIs · SNOA ownership · SNOA peers · SNOA filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.